Cargando…

Dynamics of hepatic steatosis resolution and changes in gut microbiome with weight loss in nonalcoholic fatty liver disease

BACKGROUND: Weight loss is recommended as the primary treatment for nonalcoholic fatty liver disease (NAFLD). However, the magnitude and velocity of hepatic steatosis resolution with weight loss is unclear, making it difficult to counsel patients seeking weight loss for treatment of NAFLD. The aim o...

Descripción completa

Detalles Bibliográficos
Autores principales: Behari, Jaideep, Graham, Lisa, Wang, Renwei, Schirda, Claudiu, Borhani, Amir A., Methé, Barbara A., Li, Kelvin, Morris, Alison, Luu, Hung N., Palmieri, Sabrina, Yuan, Jian‐Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019274/
https://www.ncbi.nlm.nih.gov/pubmed/33841891
http://dx.doi.org/10.1002/osp4.476
_version_ 1783674345030156288
author Behari, Jaideep
Graham, Lisa
Wang, Renwei
Schirda, Claudiu
Borhani, Amir A.
Methé, Barbara A.
Li, Kelvin
Morris, Alison
Luu, Hung N.
Palmieri, Sabrina
Yuan, Jian‐Min
author_facet Behari, Jaideep
Graham, Lisa
Wang, Renwei
Schirda, Claudiu
Borhani, Amir A.
Methé, Barbara A.
Li, Kelvin
Morris, Alison
Luu, Hung N.
Palmieri, Sabrina
Yuan, Jian‐Min
author_sort Behari, Jaideep
collection PubMed
description BACKGROUND: Weight loss is recommended as the primary treatment for nonalcoholic fatty liver disease (NAFLD). However, the magnitude and velocity of hepatic steatosis resolution with weight loss is unclear, making it difficult to counsel patients seeking weight loss for treatment of NAFLD. The aim of this study was to determine the rate of hepatic steatosis improvement and stool microbiome changes associated with rapid diet‐induced weight loss in NAFLD. METHODS: Fourteen NAFLD patients (mean ± standard deviation, body mass index [BMI] 36.4 ± 4 kg/m(2)) enrolled in a 12‐week meal replacement program underwent frequent measurement of Fibroscan‐controlled attenuation parameter (CAP). Magnetic resonance imaging (MRI‐Dixon method) for hepatic fat quantitation and stool microbiome analysis (16S rRNA gene sequencing) were completed in 11 subjects at baseline and Week 12. RESULTS: At Week 12, mean (95% confidence interval) weight loss was −13.4 (−15.2, −11.5)% and CAP score −26.6 (−35.6, −17.6)% (both Ps < 0.001). CAP scores changed at a rate of −4.9 dB/m/kg (−30.1 dB/m per unit BMI) in Weeks 1–4 and −0.6 dB/m/kg (−2.4 dB/m per unit BMI) in Weeks 8–12. MRI‐determined hepatic fat fraction decreased by −74.1% (p < 0.001) at a rate of −0.51%/kg (−3.19% per unit BMI), with complete steatosis resolution in 90% patients. BMI change was associated with decreased stool microbial diversity (coefficient = 0.17; Shannon Index), increased abundance of Prevotella_9 (Bacteroidetes; coefficient = 0.96) and decreased abundance of Phascolarctobacterium (Firmicutes; coefficient = −0.42) (both Ps < 0.05). CONCLUSIONS: Diet‐induced intensive weight loss is associated with rapid improvement and complete resolution of hepatic steatosis and decreased stool microbial diversity. These findings highlight the dynamic nature of hepatic fat and may help clinicians to develop evidence‐based treatment goals for patients with NAFLD and obesity who undertake weight loss interventions. Further research is warranted to understand the effects of intensive weight loss and gut microbiome changes on long‐term NAFLD resolution.
format Online
Article
Text
id pubmed-8019274
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-80192742021-04-08 Dynamics of hepatic steatosis resolution and changes in gut microbiome with weight loss in nonalcoholic fatty liver disease Behari, Jaideep Graham, Lisa Wang, Renwei Schirda, Claudiu Borhani, Amir A. Methé, Barbara A. Li, Kelvin Morris, Alison Luu, Hung N. Palmieri, Sabrina Yuan, Jian‐Min Obes Sci Pract Original Article BACKGROUND: Weight loss is recommended as the primary treatment for nonalcoholic fatty liver disease (NAFLD). However, the magnitude and velocity of hepatic steatosis resolution with weight loss is unclear, making it difficult to counsel patients seeking weight loss for treatment of NAFLD. The aim of this study was to determine the rate of hepatic steatosis improvement and stool microbiome changes associated with rapid diet‐induced weight loss in NAFLD. METHODS: Fourteen NAFLD patients (mean ± standard deviation, body mass index [BMI] 36.4 ± 4 kg/m(2)) enrolled in a 12‐week meal replacement program underwent frequent measurement of Fibroscan‐controlled attenuation parameter (CAP). Magnetic resonance imaging (MRI‐Dixon method) for hepatic fat quantitation and stool microbiome analysis (16S rRNA gene sequencing) were completed in 11 subjects at baseline and Week 12. RESULTS: At Week 12, mean (95% confidence interval) weight loss was −13.4 (−15.2, −11.5)% and CAP score −26.6 (−35.6, −17.6)% (both Ps < 0.001). CAP scores changed at a rate of −4.9 dB/m/kg (−30.1 dB/m per unit BMI) in Weeks 1–4 and −0.6 dB/m/kg (−2.4 dB/m per unit BMI) in Weeks 8–12. MRI‐determined hepatic fat fraction decreased by −74.1% (p < 0.001) at a rate of −0.51%/kg (−3.19% per unit BMI), with complete steatosis resolution in 90% patients. BMI change was associated with decreased stool microbial diversity (coefficient = 0.17; Shannon Index), increased abundance of Prevotella_9 (Bacteroidetes; coefficient = 0.96) and decreased abundance of Phascolarctobacterium (Firmicutes; coefficient = −0.42) (both Ps < 0.05). CONCLUSIONS: Diet‐induced intensive weight loss is associated with rapid improvement and complete resolution of hepatic steatosis and decreased stool microbial diversity. These findings highlight the dynamic nature of hepatic fat and may help clinicians to develop evidence‐based treatment goals for patients with NAFLD and obesity who undertake weight loss interventions. Further research is warranted to understand the effects of intensive weight loss and gut microbiome changes on long‐term NAFLD resolution. John Wiley and Sons Inc. 2021-01-04 /pmc/articles/PMC8019274/ /pubmed/33841891 http://dx.doi.org/10.1002/osp4.476 Text en © 2021 The Authors. Obesity Science & Practice published by World Obesity and The Obesity Society and John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Article
Behari, Jaideep
Graham, Lisa
Wang, Renwei
Schirda, Claudiu
Borhani, Amir A.
Methé, Barbara A.
Li, Kelvin
Morris, Alison
Luu, Hung N.
Palmieri, Sabrina
Yuan, Jian‐Min
Dynamics of hepatic steatosis resolution and changes in gut microbiome with weight loss in nonalcoholic fatty liver disease
title Dynamics of hepatic steatosis resolution and changes in gut microbiome with weight loss in nonalcoholic fatty liver disease
title_full Dynamics of hepatic steatosis resolution and changes in gut microbiome with weight loss in nonalcoholic fatty liver disease
title_fullStr Dynamics of hepatic steatosis resolution and changes in gut microbiome with weight loss in nonalcoholic fatty liver disease
title_full_unstemmed Dynamics of hepatic steatosis resolution and changes in gut microbiome with weight loss in nonalcoholic fatty liver disease
title_short Dynamics of hepatic steatosis resolution and changes in gut microbiome with weight loss in nonalcoholic fatty liver disease
title_sort dynamics of hepatic steatosis resolution and changes in gut microbiome with weight loss in nonalcoholic fatty liver disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019274/
https://www.ncbi.nlm.nih.gov/pubmed/33841891
http://dx.doi.org/10.1002/osp4.476
work_keys_str_mv AT beharijaideep dynamicsofhepaticsteatosisresolutionandchangesingutmicrobiomewithweightlossinnonalcoholicfattyliverdisease
AT grahamlisa dynamicsofhepaticsteatosisresolutionandchangesingutmicrobiomewithweightlossinnonalcoholicfattyliverdisease
AT wangrenwei dynamicsofhepaticsteatosisresolutionandchangesingutmicrobiomewithweightlossinnonalcoholicfattyliverdisease
AT schirdaclaudiu dynamicsofhepaticsteatosisresolutionandchangesingutmicrobiomewithweightlossinnonalcoholicfattyliverdisease
AT borhaniamira dynamicsofhepaticsteatosisresolutionandchangesingutmicrobiomewithweightlossinnonalcoholicfattyliverdisease
AT methebarbaraa dynamicsofhepaticsteatosisresolutionandchangesingutmicrobiomewithweightlossinnonalcoholicfattyliverdisease
AT likelvin dynamicsofhepaticsteatosisresolutionandchangesingutmicrobiomewithweightlossinnonalcoholicfattyliverdisease
AT morrisalison dynamicsofhepaticsteatosisresolutionandchangesingutmicrobiomewithweightlossinnonalcoholicfattyliverdisease
AT luuhungn dynamicsofhepaticsteatosisresolutionandchangesingutmicrobiomewithweightlossinnonalcoholicfattyliverdisease
AT palmierisabrina dynamicsofhepaticsteatosisresolutionandchangesingutmicrobiomewithweightlossinnonalcoholicfattyliverdisease
AT yuanjianmin dynamicsofhepaticsteatosisresolutionandchangesingutmicrobiomewithweightlossinnonalcoholicfattyliverdisease